Enliven Therapeutics Files 8-K for Material Agreement
Ticker: ELVN · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1672619
| Field | Detail |
|---|---|
| Company | Enliven Therapeutics, Inc. (ELVN) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-event
TL;DR
Enliven Therapeutics (NVTA) signed a material definitive agreement on 6/13/25. Filing details to follow.
AI Summary
Enliven Therapeutics, Inc. filed an 8-K on June 16, 2025, reporting a material definitive agreement entered into on June 13, 2025. The filing also includes other events and financial statements/exhibits. Enliven Therapeutics, formerly IMARA Inc., is incorporated in Delaware and based in Boulder, Colorado.
Why It Matters
This 8-K filing indicates a significant new agreement for Enliven Therapeutics, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce significant new risks or opportunities, requiring careful evaluation of the terms and potential impact.
Key Players & Entities
- Enliven Therapeutics, Inc. (company) — Registrant
- June 13, 2025 (date) — Date of material definitive agreement
- June 16, 2025 (date) — Filing date of the 8-K
- IMARA Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Boulder, Colorado (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement?
The filing does not specify the details of the material definitive agreement, only that one was entered into on June 13, 2025.
When was Enliven Therapeutics, Inc. formerly known as?
Enliven Therapeutics, Inc. was formerly known as IMARA Inc.
Where are Enliven Therapeutics' principal executive offices located?
Enliven Therapeutics' principal executive offices are located at 6200 Lookout Road, Boulder, Colorado, 80301.
What is the SEC file number for Enliven Therapeutics?
The SEC file number for Enliven Therapeutics is 001-39247.
What is the SIC code for Enliven Therapeutics?
The Standard Industrial Classification (SIC) code for Enliven Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Enliven Therapeutics, Inc. (ELVN).